U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 12
TABLE OF CONTENTS
1 INTRODUCTION.........................................................................................................................14
•
1.1
OBJECTIVES OF THE STUDY...........................................................................................................................................14
•
1.2
MARKET DEFINITION.......................................................................................................................................................14
•
1.3
MARKET SCOPE...............................................................................................................................................................14
•
1.3.1
MARKETS COVERED......................................................................................................................................15
•
1.3.2
YEARS CONSIDERED FOR THE STUDY.........................................................................................................16
•
1.4 CURRENCY......................................................................................................................................................................16
•
1.5 LIMITATIONS....................................................................................................................................................................16
•
1.6 STAKEHOLDERS...............................................................................................................................................................16
2
RESEARCH METHODOLOGY.....................................................................................................17
•
2.1
•
RESEARCH DATA..............................................................................................................................................................17
2.1.1
•
•
SECONDARY DATA........................................................................................................................................18
2.1.1.1
2.1.2
KEY DATA FROM SECONDARY SOURCES................................................................................18
PRIMARY DATA..............................................................................................................................................19
•
2.1.2.1
KEY DATA FROM PRIMARY SOURCES.....................................................................................19
•
2.1.2.2
KEY INDUSTRY INSIGHTS........................................................................................................20
•
2.2
MARKET SIZE ESTIMATION.............................................................................................................................................20
•
2.3
MARKET BREAKDOWN AND DATA TRIANGULATION......................................................................................................22
•
2.4
MARKET SHARE ESTIMATION.........................................................................................................................................23
•
2.5
ASSUMPTIONS FOR THE STUDY....................................................................................................................................23
3
EXECUTIVE SUMMARY..............................................................................................................24
4
PREMIUM INSIGHTS.................................................................................................................29
•
4.1
GROWTH POTENTIAL OF THE U.S. IN VITRO DIAGNOSTICS MARKET...........................................................................29
•
4.2
U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER (2014)........................................................................................30
•
4.3
U.S. IN VITRO DIAGNOSTICS MARKET, REGIONAL MIX.................................................................................................31
•
[email protected]
www.marketsandmarkets.com
12